# OnCo record te-1182 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/te-1182/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "te-1182" ;
  schema:name "TE-1182"@en ;
  schema:description "TE-1182 is an experimental antibody-drug conjugate from T-E Meds that carries two different cell-killing drugs to cancer cells with HER2 on their surface. It has been tested only in the laboratory, and the FDA has given it orphan drug status for gastric cancer."@en ;
  schema:url <https://onco.cc/drugs/te-1182/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.temeds.com/te-1182/>, <https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=1145626> ;
  onco:status "preclinical" ;
  onco:tag "pipeline", "orphan-designation" ;
  onco:modality "Dual-payload antibody-drug conjugate" ;
  onco:cancers <https://onco.cc/cancers/gastric/> ;
  onco:technologies <https://onco.cc/technologies/dual-payload-adc/> ;
  onco:targets <https://onco.cc/targets/her2/> ;
  onco:companies <https://onco.cc/companies/t-e-meds/> .